Cancer Crosslinks is an annual meeting place for the Norwegian oncology community organized since 2009 by Oslo Cancer Cluster in collaboration with Bristol-Myers Squibb and other cluster members.

The aim of Cancer Crosslinks is to stimulate the dialogue between researchers and clinicians from different disciplines, as well as to increase translational and clinical research activities and new collaborations in order to develop innovative cancer treatment.

Cancer Crosslinks is a major national meeting place for the Norwegian oncology community attracting around 300 participants from the entire country. Sweden has adopted Cancer Crosslinks, due to its attractive and well-functioning format.

Oslo Cancer Cluster members and collaborators have all stressed the importance of this national forum for researchers, oncologists, hematologist and industry representatives, and the relevance of interdisciplinary “crosslinking” with colleagues they otherwise will not meet.

Cancer Crosslinks offers the participants stimulating presentations from both national and international experts, focusing on translational cancer research and recent progress, as well as networking.


CANCER CROSSLINKS 2018: JANUARY 18 – in collaboration with Bristol-Myers Squibb and Takeda